ArticleFrontiers in psychiatry2026
Multimodal neuroimaging of locus coeruleus-default mode network connectivity for predicting dexmedetomidine response in chronic insomnia disorder.
Article in Frontiers in psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: To explore whether pre-treatment functional connectivity between the locus coeruleus (LC) and default mode network (DMN), nodal graph-theoretical features, and gray matter volume can identify chronic insomnia patients who respond poorly to dexmedetomidine patient-controlled sleep therapy (PCSL). Methods: Chronic insomnia patients underwent PCSL with sub-anesthetic dexmedetomidine and were classified as responders or non-responders based on changes in the Pittsburgh Sleep Quality Index. All patients and matched good sleeper received pre-treatment resting-state functional Magnetic Resonance Imaging (MRI) and structural MRI. Functional connectivity, graph metrics, and gray matter volumes of LC and DMN regions were extracted. Predictors were selected using univariate analysis and Least Absolute Shrinkage and Selection Operator regression (LASSO), then used in a multivariate logistic model. Model performance was assessed via Receiver Operating Characteristic (ROC), calibration, decision curve analysis, and bootstrap validation. Results: No gray matter volume differences were found between responders and non-responders except increased right hippocampal volume in non-responders versus controls. Non-responders showed widespread increased LC-DMN connectivity pre-treatment, especially between right LC and left lateral temporal cortex versus responders. Graph metrics of key nodes (temporoparietal junction, lateral temporal cortex) were significantly reduced in non-responders. Three imaging features were included in the model, achieving an AUC of 0.816 with good calibration and clinical utility. Conclusion: Pre-treatment LC-DMN functional and network topology differences may underlie variable responses to dexmedetomidine PCSL in chronic insomnia. The multimodal imaging model effectively predicts treatment sensitivity and may guide personalized interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.